Literature DB >> 25849762

Structure-Based Design of Potent and Selective Inhibitors of the Metabolic Kinase PFKFB3.

Scott Boyd1, Joanna L Brookfield2, Susan E Critchlow1, Iain A Cumming2, Nicola J Curtis1, Judit Debreczeni1, Sébastien L Degorce1, Craig Donald1, Nicola J Evans3, Sam Groombridge1, Philip Hopcroft1, Neil P Jones3, Jason G Kettle1, Scott Lamont1, Hilary J Lewis1, Philip MacFaull1, Sheila B McLoughlin2, Laurent J M Rigoreau2, James M Smith2, Steve St-Gallay1, Julie K Stock3, Andrew P Turnbull3, Edward R Wheatley3, Jon Winter1, Jonathan Wingfield1.   

Abstract

A weak screening hit with suboptimal physicochemical properties was optimized against PFKFB3 kinase using critical structure-guided insights. The resulting compounds demonstrated high selectivity over related PFKFB isoforms and modulation of the target in a cellular context. A selected example demonstrated exposure in animals following oral dosing. Examples from this series may serve as useful probes to understand the emerging biology of this metabolic target.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25849762     DOI: 10.1021/acs.jmedchem.5b00352

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  24 in total

1.  The phosphatidylethanolamine biosynthesis pathway provides a new target for cancer chemotherapy.

Authors:  Yuan Guan; Xinyu Chen; Manhong Wu; Wan Zhu; Ahmed Arslan; Saori Takeda; Mindie H Nguyen; Ravindra Majeti; Dan Thomas; Ming Zheng; Gary Peltz
Journal:  J Hepatol       Date:  2019-11-22       Impact factor: 25.083

2.  Mass Spectrometry-based Label-free Quantitative Proteomics To Study the Effect of 3PO Drug at Cellular Level.

Authors:  Sarath Babu Nukala; Giovanna Baron; Giancarlo Aldini; Marina Carini; Alfonsina D'Amato
Journal:  ACS Med Chem Lett       Date:  2019-01-11       Impact factor: 4.345

3.  Phosphoproteomic quantitation and causal analysis reveal pathways in GPVI/ITAM-mediated platelet activation programs.

Authors:  Özgün Babur; Alexander R Melrose; Jennifer M Cunliffe; John Klimek; Jiaqing Pang; Anna-Liisa I Sepp; Jevgenia Zilberman-Rudenko; Samuel Tassi Yunga; Tony Zheng; Iván Parra-Izquierdo; Jessica Minnier; Owen J T McCarty; Emek Demir; Ashok P Reddy; Phillip A Wilmarth; Larry L David; Joseph E Aslan
Journal:  Blood       Date:  2020-11-12       Impact factor: 22.113

4.  Glycolytic reprogramming of macrophages activated by NOD1 and TLR4 agonists: No association with proinflammatory cytokine production in normoxia.

Authors:  Nina E Murugina; Anna S Budikhina; Yulia A Dagil; Polina V Maximchik; Lyudmila S Balyasova; Vladimir V Murugin; Mikhail V Melnikov; Viktoriya S Sharova; Anna M Nikolaeva; Georgy Z Chkadua; Boris V Pinegin; Mikhail V Pashenkov
Journal:  J Biol Chem       Date:  2020-01-31       Impact factor: 5.157

5.  Liposomes co-Loaded with 6-Phosphofructo-2-Kinase/Fructose-2, 6-Biphosphatase 3 (PFKFB3) shRNA Plasmid and Docetaxel for the Treatment of non-small Cell Lung Cancer.

Authors:  Nusrat Chowdhury; Imran Vhora; Ketan Patel; Ravi Doddapaneni; Arindam Mondal; Mandip Singh
Journal:  Pharm Res       Date:  2017-09-05       Impact factor: 4.200

Review 6.  Endothelial Cell Metabolism.

Authors:  Guy Eelen; Pauline de Zeeuw; Lucas Treps; Ulrike Harjes; Brian W Wong; Peter Carmeliet
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

7.  [18F]ZCDD083: A PFKFB3-Targeted PET Tracer for Atherosclerotic Plaque Imaging.

Authors:  Carlo De Dominicis; Paola Perrotta; Sergio Dall'Angelo; Leonie Wyffels; Steven Staelens; G R Y De Meyer; Matteo Zanda
Journal:  ACS Med Chem Lett       Date:  2020-02-19       Impact factor: 4.345

8.  PFKFB3-mediated endothelial glycolysis promotes pulmonary hypertension.

Authors:  Yapeng Cao; Xiaoyu Zhang; Lina Wang; Qiuhua Yang; Qian Ma; Jiean Xu; Jingjing Wang; Laszlo Kovacs; Ramon J Ayon; Zhiping Liu; Min Zhang; Yaqi Zhou; Xianqiu Zeng; Yiming Xu; Yong Wang; David J Fulton; Neal L Weintraub; Rudolf Lucas; Zheng Dong; Jason X-J Yuan; Jennifer C Sullivan; Louise Meadows; Scott A Barman; Chaodong Wu; Junmin Quan; Mei Hong; Yunchao Su; Yuqing Huo
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-18       Impact factor: 11.205

9.  LncRNA wires up Hippo and Hedgehog signaling to reprogramme glucose metabolism.

Authors:  Xin Zheng; Han Han; Guang-Ping Liu; Yan-Xiu Ma; Ruo-Lang Pan; Ling-Jie Sang; Rui-Hua Li; Luo-Jia Yang; Jeffrey R Marks; Wenqi Wang; Aifu Lin
Journal:  EMBO J       Date:  2017-09-28       Impact factor: 11.598

10.  The PFKFB3 Inhibitor AZ67 Inhibits Angiogenesis Independently of Glycolysis Inhibition.

Authors:  Besa Emini Veseli; Pieter Van Wielendaele; Mirela Delibegovic; Wim Martinet; Guido R Y De Meyer
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.